Manulife (Manufacturers Life Insurance)’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $513K | Sell |
37,476
-706
| -2% | -$9.67K | ﹤0.01% | 2166 |
|
|
2025
Q1 | $422K | Buy |
38,182
+696
| +2% | +$7.7K | ﹤0.01% | 2222 |
|
|
2024
Q4 | $399K | Buy |
37,486
+24,006
| +178% | +$256K | ﹤0.01% | 2342 |
|
|
2024
Q3 | $171K | Buy |
13,480
+178
| +1% | +$2.26K | ﹤0.01% | 2719 |
|
|
2024
Q2 | $223K | Sell |
13,302
-19,219
| -59% | -$322K | ﹤0.01% | 2557 |
|
|
2024
Q1 | $488K | Buy |
32,521
+21,805
| +203% | +$327K | ﹤0.01% | 2224 |
|
|
2023
Q4 | $161K | Buy |
+10,716
| New | +$161K | ﹤0.01% | 2694 |
|
|
2022
Q1 | – | Sell |
-11,924
| Closed | -$113 | – | 3189 |
|
|
2021
Q4 | $113 | Sell |
11,924
-330
| -3% | -$3 | ﹤0.01% | 3037 |
|
|
2021
Q3 | $206K | Sell |
12,254
-664
| -5% | -$11.2K | ﹤0.01% | 2965 |
|
|
2021
Q2 | $197K | Buy |
12,918
+536
| +4% | +$8.17K | ﹤0.01% | 3116 |
|
|
2021
Q1 | $241K | Sell |
12,382
-117
| -0.9% | -$2.28K | ﹤0.01% | 2761 |
|
|
2020
Q4 | $225K | Buy |
12,499
+579
| +5% | +$10.4K | ﹤0.01% | 2706 |
|
|
2020
Q3 | $230K | Hold |
11,920
| – | – | ﹤0.01% | 2481 |
|
|
2020
Q2 | $303K | Sell |
11,920
-405
| -3% | -$10.3K | ﹤0.01% | 2248 |
|
|
2020
Q1 | $220K | Buy |
12,325
+543
| +5% | +$9.69K | ﹤0.01% | 2265 |
|
|
2019
Q4 | $352K | Sell |
11,782
-381
| -3% | -$11.4K | ﹤0.01% | 2246 |
|
|
2019
Q3 | $292K | Buy |
12,163
+561
| +5% | +$13.5K | ﹤0.01% | 2335 |
|
|
2019
Q2 | $417K | Buy |
+11,602
| New | +$417K | ﹤0.01% | 2156 |
|